Application of Animal Models in Cancer Research: Recent Progress and Future Prospects

References

• Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi:10.3322/caac.2149230207593
   PubMed Web of Science ®Google Scholar
• Wild CP. The global cancer burden: necessity is the mother of prevention. Nat Rev Cancer. 2019;19(3):123–124. doi:10.1038/s41568-019-0110-330683893
   PubMed Web of Science ®Google Scholar
• Schachtschneider KM, Schwind RM, Newson J, et al. The oncopig cancer model: an innovative large animal translational oncology platform. Front Oncol. 2017;7:190. doi:10.3389/fonc.2017.0019028879168
   PubMed Web of Science ®Google Scholar
• Xu C, Wu S, Schook LB, Schachtschneider KM. Translating human cancer sequences into personalized porcine cancer models. Front Oncol. 2019;9:105. doi:10.3389/fonc.2019.0010530873383
   PubMed Web of Science ®Google Scholar
• Mural RJ, Adams MD, Myers EW, et al. A comparison of whole-genome shotgun-derived mouse chromosome 16 and the human genome. Science. 2002;296(5573):1661–1671. doi:10.1126/science.106919312040188
   PubMed Web of Science ®Google Scholar
• Mendes N, Dias Carvalho P, Martins F, et al. Animal models to study cancer and its microenvironment. Adv Exp Med Biol. 2020;1219:389–401.32130710
   PubMed Web of Science ®Google Scholar
• Liu Y, Yin T, Feng Y, et al. Mammalian models of chemically induced primary malignancies exploitable for imaging-based preclinical theragnostic research. Quant Imaging Med Surg. 2015;5(5):708–729. doi:10.3978/j.issn.2223-4292.2015.06.0126682141
   PubMed Web of Science ®Google Scholar
• De Minicis S, Kisseleva T, Francis H, et al. Liver carcinogenesis: rodent models of hepatocarcinoma and cholangiocarcinoma. Dig Liver Dis. 2013;45(6):450–459. doi:10.1016/j.dld.2012.10.00823177172
   PubMedGoogle Scholar
• Brennecke P, Arlt MJ, Campanile C, et al. CXCR4 antibody treatment suppresses metastatic spread to the lung of intratibial human osteosarcoma xenografts in mice. Clin Exp Metastasis. 2014;31(3):339–349. doi:10.1007/s10585-013-9632-324390633
   PubMed Web of Science ®Google Scholar
• Ye F, Chen C, Qin J, Liu J, Zheng C. Genetic profiling reveals an alarming rate of cross-contamination among human cell lines used in China. FASEB J. 2015;29(10):4268–4272. doi:10.1096/fj.14-26671826116706
   PubMed Web of Science ®Google Scholar
• Hidalgo M, Amant F, Biankin AV, et al. Patient-derived xenograft models: an emerging platform for translational cancer research. Cancer Discov. 2014;4(9):998–1013. doi:10.1158/2159-8290.CD-14-000125185190
   PubMed Web of Science ®Google Scholar
• Hooijkaas AI, Gadiot J, van der Valk M, Mooi WJ, Blank CU. Targeting BRAFV600E in an inducible murine model of melanoma. Am J Pathol. 2012;181(3):785–794. doi:10.1016/j.ajpath.2012.06.00222796458
   PubMed Web of Science ®Google Scholar
• Chen Z, Trotman LC, Shaffer D, et al. Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis. Nature. 2005;436(7051):725–730. doi:10.1038/nature0391816079851
   PubMed Web of Science ®Google Scholar
• Kersten K, de Visser KE, van Miltenburg MH, Jonkers J. Genetically engineered mouse models in oncology research and cancer medicine. EMBO Mol Med. 2017;9(2):137–153. doi:10.15252/emmm.20160685728028012
   PubMed Web of Science ®Google Scholar
• Shultz LD, Brehm MA, Garcia-Martinez JV, Greiner DL. Humanized mice for immune system investigation: progress, promise and challenges. Nat Rev Immunol. 2012;12(11):786–798. doi:10.1038/nri331123059428
   PubMed Web of Science ®Google Scholar
• Sanmamed MF, Rodriguez I, Schalper KA, et al. Nivolumab and urelumab enhance antitumor activity of human T lymphocytes engrafted in Rag2-/-IL2Rgammanull immunodeficient mice. Cancer Res. 2015;75(17):3466–3478. doi:10.1158/0008-5472.CAN-14-351026113085
   PubMed Web of Science ®Google Scholar
• Ashizawa T, Iizuka A, Nonomura C, et al. Antitumor effect of programmed death-1 (PD-1) blockade in humanized the NOG-MHC double knockout mouse. Clin Cancer Res. 2017;23(1):149–158. doi:10.1158/1078-0432.CCR-16-012227458246
   PubMed Web of Science ®Google Scholar
• Roth MD, Harui A. Human tumor infiltrating lymphocytes cooperatively regulate prostate tumor growth in a humanized mouse model. J Immunother Cancer. 2015;3:12. doi:10.1186/s40425-015-0056-225901284
   PubMed Web of Science ®Google Scholar
• Wang L, Wen W, Yuan J, et al. Immunotherapy for human renal cell carcinoma by adoptive transfer of autologous transforming growth factor beta-insensitive CD8+ T cells. Clin Cancer Res. 2010;16(1):164–173. doi:10.1158/1078-0432.CCR-09-175820028741
   PubMed Web of Science ®Google Scholar
• Melkus MW, Estes JD, Padgett-Thomas A, et al. Humanized mice mount specific adaptive and innate immune responses to EBV and TSST-1. Nat Med. 2006;12(11):1316–1322. doi:10.1038/nm143117057712
   PubMed Web of Science ®Google Scholar
• Wege AK, Melkus MW, Denton PW, Estes JD, Garcia JV. Functional and phenotypic characterization of the humanized BLT mouse model. Curr Top Microbiol Immunol. 2008;324:149–165. doi:10.1007/978-3-540-75647-7_1018481459
   PubMed Web of Science ®Google Scholar
• Shimizu S, Hong P, Arumugam B, et al. A highly efficient short hairpin RNA potently down-regulates CCR5 expression in systemic lymphoid organs in the hu-BLT mouse model. Blood. 2010;115(8):1534–1544. doi:10.1182/blood-2009-04-21585520018916
   PubMed Web of Science ®Google Scholar
• Vatakis DN, Koya RC, Nixon CC, et al. Antitumor activity from antigen-specific CD8 T cells generated in vivo from genetically engineered human hematopoietic stem cells. Proc Natl Acad Sci U S A. 2011;108(51):E1408–E1416. doi:10.1073/pnas.111505010822123951
   PubMed Web of Science ®Google Scholar
• Kaur K, Kozlowska AK, Topchyan P, et al. Probiotic-treated super-charged NK cells efficiently clear poorly differentiated pancreatic tumors in Hu-BLT mice. Cancers (Basel). 2019;12(1):63. doi:10.3390/cancers12010063
   PubMed Web of Science ®Google Scholar
• Reardon S. Trump administration halts fetal-tissue research by government scientists. Nature. 2019;570(7760):148. doi:10.1038/d41586-019-01783-6
   PubMed Web of Science ®Google Scholar
• Rongvaux A, Takizawa H, Strowig T, et al. Human hemato-lymphoid system mice: current use and future potential for medicine. Annu Rev Immunol. 2013;31:635–674. doi:10.1146/annurev-immunol-032712-09592123330956
   PubMed Web of Science ®Google Scholar
• Meraz IM, Majidi M, Meng F, et al. An improved patient-derived xenograft humanized mouse model for evaluation of lung cancer immune responses. Cancer Immunol Res. 2019;7(8):1267–1279. doi:10.1158/2326-6066.CIR-18-087431186248
   PubMed Web of Science ®Google Scholar
• Lin S, Huang G, Cheng L, et al. Establishment of peripheral blood mononuclear cell-derived humanized lung cancer mouse models for studying efficacy of PD-L1/PD-1 targeted immunotherapy. MAbs. 2018;10(8):1301–1311. doi:10.1080/19420862.2018.151894830204048
   PubMed Web of Science ®Google Scholar
• Liu G, Fan X, Cai Y, et al. Efficacy of dendritic cell-based immunotherapy produced from cord blood in vitro and in a humanized NSG mouse cancer model. Immunotherapy. 2019;11(7):599–616. doi:10.2217/imt-2018-010330943862
   PubMed Web of Science ®Google Scholar
• Legrand N, Weijer K, Spits H. Experimental models to study development and function of the human immune system in vivo. J Immunol. 2006;176(4):2053–2058. doi:10.4049/jimmunol.176.4.205316455958
   PubMed Web of Science ®Google Scholar
• Pyo KH, Kim JH, Lee JM, et al. Promising preclinical platform for evaluation of immuno-oncology drugs using Hu-PBL-NSG lung cancer models. Lung Cancer. 2019;127:112–121. doi:10.1016/j.lungcan.2018.11.03530642538
   PubMed Web of Science ®Google Scholar
• Gyory F, Mezosi E, Szakall S, et al. Establishment of the hu-PBL-SCID mouse model for the investigation of thyroid cancer. Exp Clin Endocrinol Diabetes. 2005;113(7):359–364. doi:10.1055/s-2005-86574016025395
   PubMed Web of Science ®Google Scholar
• Liang ZX, Cheng Q, Chen HZ, Xie X, Ye DF. [Development of HPV16 positive cervical cancer model in the hu-PBL-SCID mouse and its immunological features]. Zhonghua Yi Xue Za Zhi. 2004;84(17):1465–1469. Chinese.15500747
   PubMedGoogle Scholar
• Chung MA, Luo Y, O’Donnell M, et al. Development and preclinical evaluation of a Bacillus Calmette-Guerin-MUC1-based novel breast cancer vaccine. Cancer Res. 2003;63(6):1280–1287.12649188
   PubMed Web of Science ®Google Scholar
• Wang JJ, Liu YH, Li GC. Induction of protective and therapeutic anti-cancer immunity by using bispecific anti-idiotype antibody G22-I50 for nasopharyngeal carcinoma. Int Immunopharmacol. 2015;28(2):1026–1033. doi:10.1016/j.intimp.2015.07.02626303768
   PubMed Web of Science ®Google Scholar
• Teittinen KJ, Gronroos T, Parikka M, Ramet M, Lohi O. The zebrafish as a tool in leukemia research. Leuk Res. 2012;36(9):1082–1088. doi:10.1016/j.leukres.2012.06.00122749067
   PubMed Web of Science ®Google Scholar
• Konantz M, Balci TB, Hartwig UF, et al. Zebrafish xenografts as a tool for in vivo studies on human cancer. Ann N Y Acad Sci. 2012;1266:124–137. doi:10.1111/j.1749-6632.2012.06575.x22901264
   PubMed Web of Science ®Google Scholar
• Veinotte CJ, Dellaire G, Berman JN. Hooking the big one: the potential of zebrafish xenotransplantation to reform cancer drug screening in the genomic era. Dis Model Mech. 2014;7(7):745–754. doi:10.1242/dmm.01578424973744
   PubMed Web of Science ®Google Scholar
• White RM, Sessa A, Burke C, et al. Transparent adult zebrafish as a tool for in vivo transplantation analysis. Cell Stem Cell. 2008;2(2):183–189. doi:10.1016/j.stem.2007.11.00218371439
   PubMed Web of Science ®Google Scholar
• Tang Q, Moore JC, Ignatius MS, et al. Imaging tumour cell heterogeneity following cell transplantation into optically clear immune-deficient zebrafish. Nat Commun. 2016;7:10358. doi:10.1038/ncomms1035826790525
   PubMed Web of Science ®Google Scholar
• Tsao H, Fukunaga-Kalabis M, Herlyn M. Recent advances in melanoma and melanocyte biology. J Invest Dermatol. 2017;137(3):557–560. doi:10.1016/j.jid.2016.11.00428089201
   PubMed Web of Science ®Google Scholar
• Gru AA, Becker N, Dehner LP, Pfeifer JD. Mucosal melanoma: correlation of clinicopathologic, prognostic, and molecular features. Melanoma Res. 2014;24(4):360–370. doi:10.1097/CMR.000000000000008224870295
   PubMed Web of Science ®Google Scholar
• Olsen CM, Lane SW, Green AC. Increased risk of melanoma in patients with chronic lymphocytic leukaemia: systematic review and meta-analysis of cohort studies. Melanoma Res. 2016;26(2):188–194. doi:10.1097/CMR.000000000000021926630660
   PubMed Web of Science ®Google Scholar
• Dovey M, White RM, Zon LI. Oncogenic NRAS cooperates with p53 loss to generate melanoma in zebrafish. Zebrafish. 2009;6(4):397–404. doi:10.1089/zeb.2009.060619954345
   PubMed Web of Science ®Google Scholar
• Fornabaio G, Barnhill RL, Lugassy C, et al. Angiotropism and extravascular migratory metastasis in cutaneous and uveal melanoma progression in a zebrafish model. Sci Rep. 2018;8(1):10448. doi:10.1038/s41598-018-28515-629992995
   PubMed Web of Science ®Google Scholar
• Gomez-Abenza E, Ibanez-Molero S, Garcia-Moreno D, et al. Zebrafish modeling reveals that SPINT1 regulates the aggressiveness of skin cutaneous melanoma and its crosstalk with tumor immune microenvironment. J Exp Clin Cancer Res. 2019;38(1):405. doi:10.1186/s13046-019-1389-331519199
   PubMed Web of Science ®Google Scholar
• Gabellini C, Gomez-Abenza E, Ibanez-Molero S, et al. Interleukin 8 mediates bcl-xL-induced enhancement of human melanoma cell dissemination and angiogenesis in a zebrafish xenograft model. Int J Cancer. 2018;142(3):584–596. doi:10.1002/ijc.3107528949016
   PubMed Web of Science ®Google Scholar
• Jing L, Zon LI. Zebrafish as a model for normal and malignant hematopoiesis. Dis Model Mech. 2011;4(4):433–438. doi:10.1242/dmm.00679121708900
   PubMed Web of Science ®Google Scholar
• Langenau DM, Traver D, Ferrando AA, et al. Myc-induced T cell leukemia in transgenic zebrafish. Science. 2003;299(5608):887–890. doi:10.1126/science.108028012574629
   PubMed Web of Science ®Google Scholar
• Gutierrez A, Grebliunaite R, Feng H, et al. Pten mediates Myc oncogene dependence in a conditional zebrafish model of T cell acute lymphoblastic leukemia. J Exp Med. 2011;208(8):1595–1603. doi:10.1084/jem.2010169121727187
   PubMed Web of Science ®Google Scholar
• Corkery DP, Dellaire G, Berman JN. Leukaemia xenotransplantation in zebrafish–chemotherapy response assay in vivo. Br J Haematol. 2011;153(6):786–789. doi:10.1111/j.1365-2141.2011.08661.x21517816
   PubMed Web of Science ®Google Scholar
• Yeh JR, Munson KM, Elagib KE, Goldfarb AN, Sweetser DA, Peterson RT. Discovering chemical modifiers of oncogene-regulated hematopoietic differentiation. Nat Chem Biol. 2009;5(4):236–243. doi:10.1038/nchembio.14719172146
   PubMed Web of Science ®Google Scholar
• Gutierrez A, Pan L, Groen RW, et al. Phenothiazines induce PP2A-mediated apoptosis in T cell acute lymphoblastic leukemia. J Clin Invest. 2014;124(2):644–655. doi:10.1172/JCI6509324401270
   PubMed Web of Science ®Google Scholar
• Ridges S, Heaton WL, Joshi D, et al. Zebrafish screen identifies novel compound with selective toxicity against leukemia. Blood. 2012;119(24):5621–5631. doi:10.1182/blood-2011-12-39881822490804
   PubMed Web of Science ®Google Scholar
• Wallace KN, Pack M. Unique and conserved aspects of gut development in zebrafish. Dev Biol. 2003;255(1):12–29. doi:10.1016/S0012-1606(02)00034-912618131
   PubMed Web of Science ®Google Scholar
• Tsering J, Hu X. Triphala suppresses growth and migration of human gastric carcinoma cells in vitro and in a zebrafish xenograft model. Biomed Res Int. 2018;2018:7046927. doi:10.1155/2018/704692730643816
   PubMed Web of Science ®Google Scholar
• Lam SH, Wu YL, Vega VB, et al. Conservation of gene expression signatures between zebrafish and human liver tumors and tumor progression. Nat Biotechnol. 2006;24(1):73–75. doi:10.1038/nbt116916327811
   PubMed Web of Science ®Google Scholar
• Yan C, Yang Q, Gong Z. Activation of hepatic stellate cells during liver carcinogenesis requires fibrinogen/integrin alphavbeta5 in zebrafish. Neoplasia. 2018;20(5):533–542. doi:10.1016/j.neo.2018.02.00229649779
   PubMed Web of Science ®Google Scholar
• Jung IH, Choi JH, Chung YY, Lim GL, Park YN, Park SW. Predominant activation of JAK/STAT3 pathway by interleukin-6 is implicated in hepatocarcinogenesis. Neoplasia. 2015;17(7):586–597. doi:10.1016/j.neo.2015.07.00526297436
   PubMed Web of Science ®Google Scholar
• Topi G, Satapathy SR, Dash P, et al. Tumour-suppressive effect of oestrogen receptor beta in colorectal cancer patients, colon cancer cells, and a zebrafish model. J Pathol. 2020;251(3):297–309. doi:10.1002/path.545332333795
   PubMed Web of Science ®Google Scholar
• Lu JW, Raghuram D, Fong PA, Gong Z. Inducible intestine-specific expression of kras(V12) triggers intestinal tumorigenesis in transgenic zebrafish. Neoplasia. 2018;20(12):1187–1197. doi:10.1016/j.neo.2018.10.00230390498
   PubMed Web of Science ®Google Scholar
• Menke AL, Spitsbergen JM, Wolterbeek AP, Woutersen RA. Normal anatomy and histology of the adult zebrafish. Toxicol Pathol. 2011;39(5):759–775. doi:10.1177/019262331140959721636695
   PubMed Web of Science ®Google Scholar
• Guo M, Wei H, Hu J, Sun S, Long J, Wang X. U0126 inhibits pancreatic cancer progression via the KRAS signaling pathway in a zebrafish xenotransplantation model. Oncol Rep. 2015;34(2):699–706. doi:10.3892/or.2015.401926035715
   PubMed Web of Science ®Google Scholar
• Fahad Ullah M. Breast cancer: current perspectives on the disease status. Adv Exp Med Biol. 2019;1152:51–64.31456179
   PubMed Web of Science ®Google Scholar
• McCarthy A, Savage K, Gabriel A, Naceur C, Reis-Filho JS, Ashworth A. A mouse model of basal-like breast carcinoma with metaplastic elements. J Pathol. 2007;211(4):389–398.17212342
   PubMed Web of Science ®Google Scholar
• Fantozzi A, Christofori G. Mouse models of breast cancer metastasis. Breast Cancer Res. 2006;8(4):212. doi:10.1186/bcr153016887003
   PubMed Web of Science ®Google Scholar
• Ren J, Smid M, Iaria J, et al. Cancer-associated fibroblast-derived Gremlin 1 promotes breast cancer progression. Breast Cancer Res. 2019;21(1):109. doi:10.1186/s13058-019-1194-031533776
   PubMed Web of Science ®Google Scholar
• Zhu XY, Guo DW, Lao QC, et al. Sensitization and synergistic anti-cancer effects of Furanodiene identified in zebrafish models. Sci Rep. 2019;9(1):4541. doi:10.1038/s41598-019-40866-230872660
   PubMed Web of Science ®Google Scholar
• Shen W, Pu J, Sun J, et al. Zebrafish xenograft model of human lung cancer for studying the function of LINC00152 in cell proliferation and invasion. Cancer Cell Int. 2020;20:376. doi:10.1186/s12935-020-01460-z32774169
   PubMed Web of Science ®Google Scholar
• Huang HW, Bow YD, Wang CY, et al. DFIQ, a novel quinoline derivative, shows anticancer potential by inducing apoptosis and autophagy in NSCLC cell and in vivo zebrafish xenograft models. Cancers (Basel). 2020;12(5):1348. doi:10.3390/cancers12051348
   PubMed Web of Science ®Google Scholar
• Keysar SB, Astling DP, Anderson RT, et al. A patient tumor transplant model of squamous cell cancer identifies PI3K inhibitors as candidate therapeutics in defined molecular bins. Mol Oncol. 2013;7(4):776–790. doi:10.1016/j.molonc.2013.03.00423607916
   PubMed Web of Science ®Google Scholar
• Morton CL, Houghton PJ. Establishment of human tumor xenografts in immunodeficient mice. Nat Protoc. 2007;2(2):247–250. doi:10.1038/nprot.2007.2517406581
   PubMed Web of Science ®Google Scholar
• Wang Y, Sudilovsky D, Zhang B, et al. A human prostatic epithelial model of hormonal carcinogenesis. Cancer Res. 2001;61(16):6064–6072.11507055
   PubMed Web of Science ®Google Scholar
• Owonikoko TK, Zhang G, Kim HS, et al. Patient-derived xenografts faithfully replicated clinical outcome in a Phase II co-clinical trial of arsenic trioxide in relapsed small cell lung cancer. J Transl Med. 2016;14(1):111. doi:10.1186/s12967-016-0861-527142472
   PubMed Web of Science ®Google Scholar
• Marangoni E, Vincent-Salomon A, Auger N, et al. A new model of patient tumor-derived breast cancer xenografts for preclinical assays. Clin Cancer Res. 2007;13(13):3989–3998. doi:10.1158/1078-0432.CCR-07-007817606733
   PubMed Web of Science ®Google Scholar
• Dodbiba L, Teichman J, Fleet A, et al. Primary esophageal and gastro-esophageal junction cancer xenograft models: clinicopathological features and engraftment. Lab Invest. 2013;93(4):397–407. doi:10.1038/labinvest.2013.823399854
   PubMed Web of Science ®Google Scholar
• El-Rifai W, Harper JC, Cummings OW, et al. Consistent genetic alterations in xenografts of proximal stomach and gastro-esophageal junction adenocarcinomas. Cancer Res. 1998;58(1):34–37.9426053
   PubMed Web of Science ®Google Scholar
• Tanaskovic O, Verga Falzacappa MV, Pelicci PG, Kim CH. Human cord blood (hCB)-CD34+ humanized mice fail to reject human acute myeloid leukemia cells. PLoS One. 2019;14(9):e0217345. doi:10.1371/journal.pone.021734531536492
   PubMed Web of Science ®Google Scholar
• Moyer AM, Yu J, Sinnwell JP, et al. Spontaneous murine tumors in the development of patient-derived xenografts: a potential pitfall. Oncotarget. 2019;10(39):3924–3930. doi:10.18632/oncotarget.2700131231469
   PubMedGoogle Scholar
• Giraud J, Bouriez D, Seeneevassen L, et al. Orthotopic patient-derived xenografts of gastric cancer to decipher drugs effects on cancer stem cells and metastatic dissemination. Cancers (Basel). 2019;11(4):560. doi:10.3390/cancers11040560
   PubMed Web of Science ®Google Scholar
• Morton JJ, Bird G, Keysar SB, et al. XactMice: humanizing mouse bone marrow enables microenvironment reconstitution in a patient-derived xenograft model of head and neck cancer. Oncogene. 2016;35(3):290–300. doi:10.1038/onc.2015.9425893296
   PubMed Web of Science ®Google Scholar
• Rongvaux A, Willinger T, Martinek J, et al. Development and function of human innate immune cells in a humanized mouse model. Nat Biotechnol. 2014;32(4):364–372. doi:10.1038/nbt.285824633240
   PubMed Web of Science ®Google Scholar
• Wang X, Qi Z, Wei H, Tian Z, Sun R. Characterization of human B cells in umbilical cord blood-transplanted NOD/SCID mice. Transpl Immunol. 2012;26(2–3):156–162. doi:10.1016/j.trim.2011.12.00322198522
   PubMed Web of Science ®Google Scholar
• Rosato RR, Davila-Gonzalez D, Choi DS, et al. Evaluation of anti-PD-1-based therapy against triple-negative breast cancer patient-derived xenograft tumors engrafted in humanized mouse models. Breast Cancer Res. 2018;20(1):108. doi:10.1186/s13058-018-1037-430185216
   PubMed Web of Science ®Google Scholar
• Danisch S, Slabik C, Cornelius A, et al. Spatiotemporally skewed activation of programmed cell death receptor 1-positive T cells after epstein-barr virus infection and tumor development in long-term fully humanized mice. Am J Pathol. 2019;189(3):521–539. doi:10.1016/j.ajpath.2018.11.01430593822
   PubMed Web of Science ®Google Scholar
• Sicklick JK, Leonard SY, Babicky ML, et al. Generation of orthotopic patient-derived xenografts from gastrointestinal stromal tumor. J Transl Med. 2014;12:41. doi:10.1186/1479-5876-12-4124507750
   PubMed Web of Science ®Google Scholar
• Hiroshima Y, Zhang Y, Zhang N, et al. Establishment of a patient-derived orthotopic Xenograft (PDOX) model of HER-2-positive cervical cancer expressing the clinical metastatic pattern. PLoS One. 2015;10(2):e0117417. doi:10.1371/journal.pone.011741725689852
   PubMed Web of Science ®Google Scholar
• Hiroshima Y, Maawy A, Zhang Y, et al. Patient-derived mouse models of cancer need to be orthotopic in order to evaluate targeted anti-metastatic therapy. Oncotarget. 2016;7(44):71696–71702. doi:10.18632/oncotarget.1232227765934
   PubMedGoogle Scholar
• Igarashi K, Kawaguchi K, Kiyuna T, et al. Patient-derived orthotopic xenograft (PDOX) mouse model of adult rhabdomyosarcoma invades and recurs after resection in contrast to the subcutaneous ectopic model. Cell Cycle. 2017;16(1):91–94. doi:10.1080/15384101.2016.125288527830986
   PubMed Web of Science ®Google Scholar
• Zhang F, Wang W, Long Y, et al. Characterization of drug responses of mini patient-derived xenografts in mice for predicting cancer patient clinical therapeutic response. Cancer Commun (Lond). 2018;38(1):60. doi:10.1186/s40880-018-0329-530257718
   PubMed Web of Science ®Google Scholar
• Frank ND, Jones ME, Vang B, et al. Evaluation of reagents used to coat the hollow-fiber bioreactor membrane of the Quantum(R) Cell Expansion System for the culture of human mesenchymal stem cells. Mater Sci Eng C Mater Biol Appl. 2019;96:77–85. doi:10.1016/j.msec.2018.10.08130606590
   PubMed Web of Science ®Google Scholar
• Zhan M, Yang RM, Wang H, et al. Guided chemotherapy based on patient-derived mini-xenograft models improves survival of gallbladder carcinoma patients. Cancer Commun (Lond). 2018;38(1):48. doi:10.1186/s40880-018-0318-830016995
   PubMed Web of Science ®Google Scholar
• Mei LJ, Yang XJ, Tang L, Hassan AH, Yonemura Y, Li Y. Establishment and identification of a rabbit model of peritoneal carcinomatosis from gastric cancer. BMC Cancer. 2010;10:124. doi:10.1186/1471-2407-10-12420359350
   PubMed Web of Science ®Google Scholar
• Pinho SS, Carvalho S, Cabral J, Reis CA, Gartner F. Canine tumors: a spontaneous animal model of human carcinogenesis. Transl Res. 2012;159(3):165–172. doi:10.1016/j.trsl.2011.11.00522340765
   PubMed Web of Science ®Google Scholar
• Gardner HL, Fenger JM, London CA. Dogs as a model for cancer. Annu Rev Anim Biosci. 2016;4:199–222. doi:10.1146/annurev-animal-022114-11091126566160
   PubMed Web of Science ®Google Scholar
• Uva P, Aurisicchio L, Watters J, et al. Comparative expression pathway analysis of human and canine mammary tumors. BMC Genomics. 2009;10:135. doi:10.1186/1471-2164-10-13519327144
   PubMed Web of Science ®Google Scholar
• Ressel L, Millanta F, Caleri E, Innocenti VM, Poli A. Reduced PTEN protein expression and its prognostic implications in canine and feline mammary tumors. Vet Pathol. 2009;46(5):860–868. doi:10.1354/vp.08-VP-0273-P-FL19429983
   PubMed Web of Science ®Google Scholar
• Puente XS, Velasco G, Gutierrez-Fernandez A, Bertranpetit J, King MC, Lopez-Otin C. Comparative analysis of cancer genes in the human and chimpanzee genomes. BMC Genomics. 2006;7:15. doi:10.1186/1471-2164-7-1516438707
   PubMed Web of Science ®Google Scholar
• Pouladi MA, Morton AJ, Hayden MR. Choosing an animal model for the study of Huntington’s disease. Nat Rev Neurosci. 2013;14(10):708–721. doi:10.1038/nrn357024052178
   PubMed Web of Science ®Google Scholar
• Fan Y, Huang ZY, Cao CC, et al. Genome of the Chinese tree shrew. Nat Commun. 2013;4:1426. doi:10.1038/ncomms241623385571
   PubMed Web of Science ®Google Scholar
• Tu Q, Yang D, Zhang X, et al. A novel pancreatic cancer model originated from transformation of acinar cells in adult tree shrew, a primate-like animal. Dis Model Mech. 2019;12(4):dmm038703. doi:10.1242/dmm.03870330910991
   PubMed Web of Science ®Google Scholar
• Ge GZ, Xia HJ, He BL, et al. Generation and characterization of a breast carcinoma model by PyMT overexpression in mammary epithelial cells of tree shrew, an animal close to primates in evolution. Int J Cancer. 2016;138(3):642–651. doi:10.1002/ijc.2981426296387
   PubMed Web of Science ®Google Scholar
• Schachtschneider KM, Madsen O, Park C, Rund LA, Groenen MA, Schook LB. Adult porcine genome-wide DNA methylation patterns support pigs as a biomedical model. BMC Genomics. 2015;16:743. doi:10.1186/s12864-015-1938-x26438392
   PubMed Web of Science ®Google Scholar
• Groenen MA, Archibald AL, Uenishi H, et al. Analyses of pig genomes provide insight into porcine demography and evolution. Nature. 2012;491(7424):393–398. doi:10.1038/nature1162223151582
   PubMed Web of Science ®Google Scholar
• Mitchell J, Tinkey PT, Avritscher R, et al. Validation of a preclinical model of diethylnitrosamine-induced hepatic neoplasia in yucatan miniature pigs. Oncology. 2016;91(2):90–100. doi:10.1159/00044607427305144
   PubMed Web of Science ®Google Scholar
• Wang K, Jin Q, Ruan D, et al. Cre-dependent Cas9-expressing pigs enable efficient in vivo genome editing. Genome Res. 2017;27(12):2061–2071. doi:10.1101/gr.222521.11729146772
   PubMed Web of Science ®Google Scholar
• Roth WJ, Kissinger CB, McCain RR, et al. Assessment of juvenile pigs to serve as human pediatric surrogates for preclinical formulation pharmacokinetic testing. AAPS J. 2013;15(3):763–774. doi:10.1208/s12248-013-9482-623595360
   PubMed Web of Science ®Google Scholar
• Kucharavy A, Rubinstein B, Zhu J, Li R, Mogilner A. Robustness and evolvability of heterogeneous cell populations. Mol Biol Cell. 2018;29(11):1400–1409. doi:10.1091/mbc.E18-01-007029851566
   PubMed Web of Science ®Google Scholar
• Leidy-Davis T, Cheng K, Goodwin LO, et al. Viable mice with extensive gene humanization (25-kbp) created using embryonic stem cell/blastocyst and CRISPR/zygote injection approaches. Sci Rep. 2018;8(1):15028. doi:10.1038/s41598-018-33408-930301924
   PubMed Web of Science ®Google Scholar
• Borga C, Park G, Foster C, et al. Simultaneous B and T cell acute lymphoblastic leukemias in zebrafish driven by transgenic MYC: implications for oncogenesis and lymphopoiesis. Leukemia. 2019;33(2):333–347. doi:10.1038/s41375-018-0226-630111845
   PubMed Web of Science ®Google Scholar
• Lu JW, Hsieh MS, Hou HA, Chen CY, Tien HF, Lin LI. Overexpression of SOX4 correlates with poor prognosis of acute myeloid leukemia and is leukemogenic in zebrafish. Blood Cancer J. 2017;7(8):e593. doi:10.1038/bcj.2017.7428841206
   PubMed Web of Science ®Google Scholar
• He S, Lamers GE, Beenakker JW, et al. Neutrophil-mediated experimental metastasis is enhanced by VEGFR inhibition in a zebrafish xenograft model. J Pathol. 2012;227(4):431–445. doi:10.1002/path.401322374800
   PubMed Web of Science ®Google Scholar
• Paul CD, Bishop K, Devine A, et al. Tissue architectural cues drive organ targeting of tumor cells in zebrafish. Cell Syst. 2019;9(2):187–206 e116. doi:10.1016/j.cels.2019.07.00531445892
   PubMed Web of Science ®Google Scholar
• Fenizia C, Bottino C, Corbetta S, et al. SMYD3 promotes the epithelial-mesenchymal transition in breast cancer. Nucleic Acids Res. 2019;47(3):1278–1293. doi:10.1093/nar/gky122130544196
   PubMed Web of Science ®Google Scholar
• Nadar RA, Asokan N, Degli Esposti L, et al. Preclinical evaluation of platinum-loaded hydroxyapatite nanoparticles in an embryonic zebrafish xenograft model. Nanoscale. 2020;12(25):13582–13594. doi:10.1039/D0NR04064A32555916
   PubMed Web of Science ®Google Scholar
• Basti A, Fior R, Yalin M, et al. The core-clock gene NR1D1 impacts cell motility in vitro and invasiveness in a zebrafish xenograft colon cancer model. Cancers (Basel). 2020;12(4):853. doi:10.3390/cancers12040853
   PubMed Web of Science ®Google Scholar
• Paauwe M, Schoonderwoerd MJA, Helderman R, et al. Endoglin expression on cancer-associated fibroblasts regulates invasion and stimulates colorectal cancer metastasis. Clin Cancer Res. 2018;24(24):6331–6344. doi:10.1158/1078-0432.CCR-18-032929945992
   PubMed Web of Science ®Google Scholar
• Jiang X, Liu G, Hu Z, Chen G, Chen J, Lv Z. cGAMP inhibits tumor growth in colorectal cancer metastasis through the STING/STAT3 axis in a zebrafish xenograft model. Fish Shellfish Immunol. 2019;95:220–226. doi:10.1016/j.fsi.2019.09.07531586458
   PubMed Web of Science ®Google Scholar
• Fior R, Povoa V, Mendes RV, et al. Single-cell functional and chemosensitive profiling of combinatorial colorectal therapy in zebrafish xenografts. Proc Natl Acad Sci U S A. 2017;114(39):E8234–E8243. doi:10.1073/pnas.161838911428835536
   PubMed Web of Science ®Google Scholar
• Petrovic J, Glamoclija J, Ilic-Tomic T, et al. Lectin from Laetiporus sulphureus effectively inhibits angiogenesis and tumor development in the zebrafish xenograft models of colorectal carcinoma and melanoma. Int J Biol Macromol. 2020;148:129–139. doi:10.1016/j.ijbiomac.2020.01.03331935408
   PubMed Web of Science ®Google Scholar
• Roel M, Rubiolo JA, Guerra-Varela J, et al. Marine guanidine alkaloids crambescidins inhibit tumor growth and activate intrinsic apoptotic signaling inducing tumor regression in a colorectal carcinoma zebrafish xenograft model. Oncotarget. 2016;7(50):83071–83087. doi:10.18632/oncotarget.1306827825113
   PubMedGoogle Scholar
• Banasavadi-Siddegowda YK, Welker AM, An M, et al. PRMT5 as a druggable target for glioblastoma therapy. Neuro Oncol. 2018;20(6):753–763. doi:10.1093/neuonc/nox20629106602
   PubMed Web of Science ®Google Scholar
• Nguyen AT, Emelyanov A, Koh CH, Spitsbergen JM, Parinov S, Gong Z. An inducible kras(V12) transgenic zebrafish model for liver tumorigenesis and chemical drug screening. Dis Model Mech. 2012;5(1):63–72. doi:10.1242/dmm.00836721903676
   PubMed Web of Science ®Google Scholar
• Li Z, Zheng W, Wang Z, et al. A transgenic zebrafish liver tumor model with inducible Myc expression reveals conserved Myc signatures with mammalian liver tumors. Dis Model Mech. 2013;6(2):414–423. doi:10.1242/dmm.01046223038063
   PubMed Web of Science ®Google Scholar
• Mizgireuv IV, Majorova IG, Gorodinskaya VM, Khudoley VV, Revskoy SY. Carcinogenic effect of N-nitrosodimethylamine on diploid and triploid zebrafish (Danio rerio). Toxicol Pathol. 2004;32(5):514–518. doi:10.1080/0192623049049631115603536
   PubMed Web of Science ®Google Scholar
• Shwartz A, Goessling W, Yin C. Macrophages in zebrafish models of liver diseases. Front Immunol. 2019;10:2840. doi:10.3389/fimmu.2019.0284031867007
   PubMed Web of Science ®Google Scholar
• Yang Q, Yan C, Gong Z. Activation of liver stromal cells is associated with male-biased liver tumor initiation in xmrk and Myc transgenic zebrafish. Sci Rep. 2017;7(1):10315. doi:10.1038/s41598-017-10529-128871112
   PubMed Web of Science ®Google Scholar
• Li Z, Huang X, Zhan H, et al. Inducible and repressable oncogene-addicted hepatocellular carcinoma in Tet-on xmrk transgenic zebrafish. J Hepatol. 2012;56(2):419–425. doi:10.1016/j.jhep.2011.07.02521888874
   PubMed Web of Science ®Google Scholar
• Li Z, Luo H, Li C, et al. Transcriptomic analysis of a transgenic zebrafish hepatocellular carcinoma model reveals a prominent role of immune responses in tumour progression and regression. Int J Cancer. 2014;135(7):1564–1573. doi:10.1002/ijc.2879424550086
   PubMed Web of Science ®Google Scholar
• Evason KJ, Francisco MT, Juric V, et al. Identification of chemical inhibitors of beta-catenin-driven liver tumorigenesis in zebrafish. PLoS Genet. 2015;11(7):e1005305. doi:10.1371/journal.pgen.100530526134322
   PubMed Web of Science ®Google Scholar
• Yan C, Huo X, Wang S, Feng Y, Gong Z. Stimulation of hepatocarcinogenesis by neutrophils upon induction of oncogenic kras expression in transgenic zebrafish. J Hepatol. 2015;63(2):420–428. doi:10.1016/j.jhep.2015.03.02425828472
   PubMed Web of Science ®Google Scholar
• Pruvot B, Jacquel A, Droin N, et al. Leukemic cell xenograft in zebrafish embryo for investigating drug efficacy. Haematologica. 2011;96(4):612–616. doi:10.3324/haematol.2010.03140121228037
   PubMed Web of Science ®Google Scholar
• Zhang B, Shimada Y, Kuroyanagi J, Umemoto N, Nishimura Y, Tanaka T. Quantitative phenotyping-based in vivo chemical screening in a zebrafish model of leukemia stem cell xenotransplantation. PLoS One. 2014;9(1):e85439. doi:10.1371/journal.pone.008543924454867
   PubMed Web of Science ®Google Scholar
• Yang Q, Salim L, Yan C, Gong Z. Rapid analysis of effects of environmental toxicants on tumorigenesis and inflammation using a transgenic zebrafish model for liver cancer. Mar Biotechnol (NY). 2019;21(3):396–405. doi:10.1007/s10126-019-09889-830852708
   PubMed Web of Science ®Google Scholar
• Chew TW, Liu XJ, Liu L, Spitsbergen JM, Gong Z, Low BC. Crosstalk of Ras and Rho: activation of RhoA abates Kras-induced liver tumorigenesis in transgenic zebrafish models. Oncogene. 2014;33(21):2717–2727. doi:10.1038/onc.2013.24023812423
   PubMed Web of Science ®Google Scholar
• Chiu CC, Chou HL, Chen BH, et al. BPIQ, a novel synthetic quinoline derivative, inhibits growth and induces mitochondrial apoptosis of lung cancer cells in vitro and in zebrafish xenograft model. BMC Cancer. 2015;15:962. doi:10.1186/s12885-015-1970-x26672745
   PubMed Web of Science ®Google Scholar
• Jin Y, Wei L, Jiang Q, et al. Comparison of efficacy and toxicity of bevacizumab, endostar and apatinib in transgenic and human lung cancer xenograftzebrafish model. Sci Rep. 2018;8(1):15837. doi:10.1038/s41598-018-34030-530367145
   PubMed Web of Science ®Google Scholar
• Topczewska JM, Postovit LM, Margaryan NV, et al. Embryonic and tumorigenic pathways converge via Nodal signaling: role in melanoma aggressiveness. Nat Med. 2006;12(8):925–932. doi:10.1038/nm144816892036
   PubMed Web of Science ®Google Scholar
• Patton EE, Widlund HR, Kutok JL, et al. BRAF mutations are sufficient to promote nevi formation and cooperate with p53 in the genesis of melanoma. Curr Biol. 2005;15(3):249–254. doi:10.1016/j.cub.2005.01.03115694309
   PubMed Web of Science ®Google Scholar
• Antonio N, Bonnelykke-Behrndtz ML, Ward LC, et al. The wound inflammatory response exacerbates growth of pre-neoplastic cells and progression to cancer. EMBO J. 2015;34(17):2219–2236. doi:10.15252/embj.20149014726136213
   PubMed Web of Science ®Google Scholar
• Hosono Y, Niknafs YS, Prensner JR, et al. Oncogenic role of THOR, a conserved cancer/testis long non-coding RNA. Cell. 2017;171(7):1559–1572 e1520. doi:10.1016/j.cell.2017.11.04029245011
   PubMed Web of Science ®Google Scholar
• Verykiou S, Alexander M, Edwards N, et al. Harnessing autophagy to overcome mitogen-activated protein kinase kinase inhibitor-induced resistance in metastatic melanoma. Br J Dermatol. 2019;180(2):346–356. doi:10.1111/bjd.1733330339727
   PubMed Web of Science ®Google Scholar
• Marques IJ, Weiss FU, Vlecken DH, et al. Metastatic behaviour of primary human tumours in a zebrafish xenotransplantation model. BMC Cancer. 2009;9:128. doi:10.1186/1471-2407-9-12819400945
   PubMed Web of Science ®Google Scholar
• Kendall GC, Watson S, Xu L, et al. PAX3-FOXO1 transgenic zebrafish models identify HES3 as a mediator of rhabdomyosarcoma tumorigenesis. Elife. 2018;7. doi:10.7554/eLife.33800
   PubMed Web of Science ®Google Scholar
• Bentley VL, Veinotte CJ, Corkery DP, et al. Focused chemical genomics using zebrafish xenotransplantation as a pre-clinical therapeutic platform for T-cell acute lymphoblastic leukemia. Haematologica. 2015;100(1):70–76. doi:10.3324/haematol.2014.11074225281505
   PubMed Web of Science ®Google Scholar
• Anelli V, Villefranc JA, Chhangawala S, et al. Oncogenic BRAF disrupts thyroid morphogenesis and function via twist expression. Elife. 2017;6. doi:10.7554/eLife.20728
   PubMed Web of Science ®Google Scholar
• Chen C, Choudhury S, Wangsa D, et al. A multiplex preclinical model for adenoid cystic carcinoma of the salivary gland identifies regorafenib as a potential therapeutic drug. Sci Rep. 2017;7(1):11410. doi:10.1038/s41598-017-11764-228900283
   PubMed Web of Science ®Google Scholar
• Alzubi MA, Turner TH, Olex AL, et al. Separation of breast cancer and organ microenvironment transcriptomes in metastases. Breast Cancer Res. 2019;21(1):36. doi:10.1186/s13058-019-1123-230841919
   PubMed Web of Science ®Google Scholar
• Mercatali L, La Manna F, Groenewoud A, et al. Development of a patient-derived xenograft (PDX) of breast cancer bone metastasis in a zebrafish model. Int J Mol Sci. 2016;17(8):1375. doi:10.3390/ijms17081375
   PubMed Web of Science ®Google Scholar
• Goto H, Shimono Y, Funakoshi Y, et al. Adipose-derived stem cells enhance human breast cancer growth and cancer stem cell-like properties through adipsin. Oncogene. 2019;38(6):767–779. doi:10.1038/s41388-018-0477-830177835
   PubMed Web of Science ®Google Scholar
• Evans KW, Yuca E, Akcakanat A, et al. A population of heterogeneous breast cancer patient-derived xenografts demonstrate broad activity of PARP inhibitor in BRCA1/2 wild-type tumors. Clin Cancer Res. 2017;23(21):6468–6477. doi:10.1158/1078-0432.CCR-17-061529093017
   PubMed Web of Science ®Google Scholar
• Bieniasz M, Radhakrishnan P, Faham N, De La OJ, Welm AL. Preclinical efficacy of ron kinase inhibitors alone and in combination with PI3K inhibitors for treatment of sfRon-expressing breast cancer patient-derived xenografts. Clin Cancer Res. 2015;21(24):5588–5600. doi:10.1158/1078-0432.CCR-14-328326289070
   PubMed Web of Science ®Google Scholar
• Noh JJ, Kim MS, Cho YJ, et al. Anti-cancer activity of As4O6 and its efficacy in a series of patient-derived xenografts for human cervical cancer. Pharmaceutics. 2020;12(10):987. doi:10.3390/pharmaceutics12100987
   PubMed Web of Science ®Google Scholar
• Teng R, Zhao J, Zhao Y, et al. Chimeric antigen receptor-modified T cells repressed solid tumors and their relapse in an established patient-derived colon carcinoma xenograft model. J Immunother. 2019;42(2):33–42. doi:10.1097/CJI.000000000000025130586347
   PubMed Web of Science ®Google Scholar
• Yamaguchi N, Weinberg EM, Nguyen A, et al. PCK1 and DHODH drive colorectal cancer liver metastatic colonization and hypoxic growth by promoting nucleotide synthesis. Elife. 2019;8. doi:10.7554/eLife.52135
   Web of Science ®Google Scholar
• Yao YM, Donoho GP, Iversen PW, et al. Mouse PDX trial suggests synergy of concurrent inhibition of RAF and EGFR in colorectal cancer with BRAF or KRAS mutations. Clin Cancer Res. 2017;23(18):5547–5560. doi:10.1158/1078-0432.CCR-16-325028611205
   PubMed Web of Science ®Google Scholar
• Takeda M, Koseki J, Takahashi H, et al. Disruption of endolysosomal RAB5/7 efficiently eliminates colorectal cancer stem cells. Cancer Res. 2019;79(7):1426–1437. doi:10.1158/0008-5472.CAN-18-219230765602
   PubMed Web of Science ®Google Scholar
• Kavuri SM, Jain N, Galimi F, et al. HER2 activating mutations are targets for colorectal cancer treatment. Cancer Discov. 2015;5(8):832–841. doi:10.1158/2159-8290.CD-14-121126243863
   PubMed Web of Science ®Google Scholar
• Mohamed Suhaimi NA, Phyo WM, Yap HY, et al. Metformin inhibits cellular proliferation and bioenergetics in colorectal cancer patient-derived xenografts. Mol Cancer Ther. 2017;16(9):2035–2044. doi:10.1158/1535-7163.MCT-16-079328533437
   PubMed Web of Science ®Google Scholar
• Scott AJ, Arcaroli JJ, Bagby SM, et al. Cabozantinib exhibits potent antitumor activity in colorectal cancer patient-derived tumor xenograft models via autophagy and signaling mechanisms. Mol Cancer Ther. 2018;17(10):2112–2122. doi:10.1158/1535-7163.MCT-17-013130026382
   PubMed Web of Science ®Google Scholar
• Jin G, Yao K, Guo Z, et al. APIO-EE-9 is a novel Aurora A and B antagonist that suppresses esophageal cancer growth in a PDX mouse model. Oncotarget. 2017;8(32):53387–53404. doi:10.18632/oncotarget.1850828881819
   PubMedGoogle Scholar
• Wu JQ, Zhai J, Li CY, et al. Patient-derived xenograft in zebrafish embryos: a new platform for translational research in gastric cancer. J Exp Clin Cancer Res. 2017;36(1):160. doi:10.1186/s13046-017-0631-029141689
   PubMed Web of Science ®Google Scholar
• Zhang X, Li Z, Xuan Z, et al. Novel role of miR-133a-3p in repressing gastric cancer growth and metastasis via blocking autophagy-mediated glutaminolysis. J Exp Clin Cancer Res. 2018;37(1):320. doi:10.1186/s13046-018-0993-y30572959
   PubMed Web of Science ®Google Scholar
• Zhang X, Wang S, Wang H, et al. Circular RNA circNRIP1 acts as a microRNA-149-5p sponge to promote gastric cancer progression via the AKT1/mTOR pathway. Mol Cancer. 2019;18(1):20. doi:10.1186/s12943-018-0935-530717751
   PubMed Web of Science ®Google Scholar
• Li Q, Zhu CC, Ni B, et al. Lysyl oxidase promotes liver metastasis of gastric cancer via facilitating the reciprocal interactions between tumor cells and cancer associated fibroblasts. EBioMedicine. 2019;49:157–171. doi:10.1016/j.ebiom.2019.10.03731678002
   PubMed Web of Science ®Google Scholar
• Li S, Zhuang Z, Wu T, et al. Nicotinamide nucleotide transhydrogenase-mediated redox homeostasis promotes tumor growth and metastasis in gastric cancer. Redox Biol. 2018;18:246–255. doi:10.1016/j.redox.2018.07.01730059901
   PubMed Web of Science ®Google Scholar
• Huang T, Zhou F, Yuan X, et al. Reactive oxygen species are involved in the development of gastric cancer and gastric cancer-related depression through ABL1-mediated inflammation signaling pathway. Oxid Med Cell Longev. 2019;2019:5813985. doi:10.1155/2019/581398531396300
   PubMed Web of Science ®Google Scholar
• Zu LD, Peng XC, Zeng Z, et al. Gastrin inhibits gastric cancer progression through activating the ERK-P65-miR23a/27a/24 axis. J Exp Clin Cancer Res. 2018;37(1):115. doi:10.1186/s13046-018-0782-729866191
   PubMed Web of Science ®Google Scholar
• Li C, Deng C, Pan G, et al. Lycorine hydrochloride inhibits cell proliferation and induces apoptosis through promoting FBXW7-MCL1 axis in gastric cancer. J Exp Clin Cancer Res. 2020;39(1):230. doi:10.1186/s13046-020-01743-333126914
   PubMed Web of Science ®Google Scholar
• Wang X, Fu R, Hu Y, et al. EGFR gene status predicts response and survival benefit in a preclinical gastric cancer trial treating patientderived xenografts with cetuximab. Oncol Rep. 2017;38(4):2387–2393. doi:10.3892/or.2017.590728849161
   PubMed Web of Science ®Google Scholar
• Wang Q, Zhang X, Shen E, et al. The anti-HER3 antibody in combination with trastuzumab exerts synergistic antitumor activity in HER2-positive gastric cancer. Cancer Lett. 2016;380(1):20–30.27317872
   PubMed Web of Science ®Google Scholar
• Guo X, Zhou N, Chen Z, et al. Construction of (124)I-trastuzumab for noninvasive PET imaging of HER2 expression: from patient-derived xenograft models to gastric cancer patients. Gastric Cancer. 2020;23(4):614–626. doi:10.1007/s10120-019-01035-631919745
   PubMed Web of Science ®Google Scholar
• Wu CX, Wang XQ, Chok SH, et al. Blocking CDK1/PDK1/beta-Catenin signaling by CDK1 inhibitor RO3306 increased the efficacy of sorafenib treatment by targeting cancer stem cells in a preclinical model of hepatocellular carcinoma. Theranostics. 2018;8(14):3737–3750.30083256
   PubMed Web of Science ®Google Scholar
• Harrington BS, He Y, Davies CM, et al. Cell line and patient-derived xenograft models reveal elevated CDCP1 as a target in high-grade serous ovarian cancer. Br J Cancer. 2016;114(4):417–426. doi:10.1038/bjc.2015.47126882065
   PubMed Web of Science ®Google Scholar
• Zhang S, Zheng C, Zhu W, et al. A novel anti-DR5 antibody-drug conjugate possesses a high-potential therapeutic efficacy for leukemia and solid tumors. Theranostics. 2019;9(18):5412–5423. doi:10.7150/thno.3359831410224
   PubMed Web of Science ®Google Scholar
• Katz A, Barash U, Boyango I, et al. Patient derived xenografts (PDX) predict an effective heparanase-based therapy for lung cancer. Oncotarget. 2018;9(27):19294–19306. doi:10.18632/oncotarget.2502229721203
   PubMedGoogle Scholar
• He D, Zhang J, Wu W, et al. A novel immunodeficient rat model supports human lung cancer xenografts. FASEB J. 2019;33(1):140–150. doi:10.1096/fj.201800102RR29944447
   PubMed Web of Science ®Google Scholar
• Weeden CE, Holik AZ, Young RJ, et al. Cisplatin increases sensitivity to FGFR inhibition in patient-derived xenograft models of lung squamous cell carcinoma. Mol Cancer Ther. 2017;16(8):1610–1622. doi:10.1158/1535-7163.MCT-17-017428611104
   PubMed Web of Science ®Google Scholar
• Kong Y, Sheng X, Wu X, et al. Frequent genetic aberrations in the CDK4 pathway in acral melanoma indicate the potential for CDK4/6 inhibitors in targeted therapy. Clin Cancer Res. 2017;23(22):6946–6957. doi:10.1158/1078-0432.CCR-17-007028830923
   PubMed Web of Science ®Google Scholar
• Liu DS, Read M, Cullinane C, et al. APR-246 potently inhibits tumour growth and overcomes chemoresistance in preclinical models of oesophageal adenocarcinoma. Gut. 2015;64(10):1506–1516. doi:10.1136/gutjnl-2015-30977026187504
   PubMed Web of Science ®Google Scholar
• Butler KA, Hou X, Becker MA, et al. Prevention of human lymphoproliferative tumor formation in ovarian cancer patient-derived xenografts. Neoplasia. 2017;19(8):628–636. doi:10.1016/j.neo.2017.04.00728658648
   PubMed Web of Science ®Google Scholar
• Ricci F, Guffanti F, Damia G, Broggini M. Combination of paclitaxel, bevacizumab and MEK162 in second line treatment in platinum-relapsing patient derived ovarian cancer xenografts. Mol Cancer. 2017;16(1):97. doi:10.1186/s12943-017-0662-328558767
   PubMed Web of Science ®Google Scholar
• Guo S, Gao S, Liu R, et al. Oncological and genetic factors impacting PDX model construction with NSG mice in pancreatic cancer. FASEB J. 2019;33(1):873–884. doi:10.1096/fj.201800617R30091943
   PubMed Web of Science ®Google Scholar
• Fang C, Dai CY, Mei Z, et al. microRNA-193a stimulates pancreatic cancer cell repopulation and metastasis through modulating TGF-beta2/TGF-betaRIII signalings. J Exp Clin Cancer Res. 2018;37(1):25. doi:10.1186/s13046-018-0697-329433538
   PubMed Web of Science ®Google Scholar
• Yang D, Zhang Q, Ma Y, et al. Augmenting the therapeutic efficacy of adenosine against pancreatic cancer by switching the Akt/p21-dependent senescence to apoptosis. EBioMedicine. 2019;47:114–127. doi:10.1016/j.ebiom.2019.08.06831495718
   PubMed Web of Science ®Google Scholar
• Cai W, Ratnayake R, Gerber MH, et al. Development of apratoxin S10 (Apra S10) as an anti-pancreatic cancer agent and its preliminary evaluation in an orthotopic patient-derived xenograft (PDX) model. Invest New Drugs. 2019;37(2):364–374. doi:10.1007/s10637-018-0647-030073464
   PubMed Web of Science ®Google Scholar
• Schuller AG, Barry ER, Jones RD, et al. The MET inhibitor AZD6094 (Savolitinib, HMPL-504) induces regression in papillary renal cell carcinoma patient-derived xenograft models. Clin Cancer Res. 2015;21(12):2811–2819. doi:10.1158/1078-0432.CCR-14-268525779944
   PubMed Web of Science ®Google Scholar
• Varkaris A, Corn PG, Parikh NU, et al. Integrating murine and clinical trials with cabozantinib to understand roles of MET and VEGFR2 as targets for growth inhibition of prostate cancer. Clin Cancer Res. 2016;22(1):107–121. doi:10.1158/1078-0432.CCR-15-023526272062
   PubMed Web of Science ®Google Scholar
• Tsai H, Morais CL, Alshalalfa M, et al. Cyclin D1 loss distinguishes prostatic small-cell carcinoma from most prostatic adenocarcinomas. Clin Cancer Res. 2015;21(24):5619–5629. doi:10.1158/1078-0432.CCR-15-074426246306
   PubMed Web of Science ®Google Scholar
• Hatem R, Labiod D, Chateau-Joubert S, et al. Vandetanib as a potential new treatment for estrogen receptor-negative breast cancers. Int J Cancer. 2016;138(10):2510–2521. doi:10.1002/ijc.2997426686064
   PubMed Web of Science ®Google Scholar
• Laird JH, Lok BH, Ma J, et al. Talazoparib is a potent radiosensitizer in small cell lung cancer cell lines and xenografts. Clin Cancer Res. 2018;24(20):5143–5152. doi:10.1158/1078-0432.CCR-18-040129945991
   PubMed Web of Science ®Google Scholar
• Gonzalez-Gonzalez A, Munoz-Muela E, Marchal JA, et al. Activating transcription factor 4 modulates TGFbeta-induced aggressiveness in triple-negative breast cancer via SMAD2/3/4 and mTORC2 signaling. Clin Cancer Res. 2018;24(22):5697–5709. doi:10.1158/1078-0432.CCR-17-312530012564
   PubMed Web of Science ®Google Scholar
• Marangoni E, Laurent C, Coussy F, et al. Capecitabine efficacy is correlated with TYMP and RB1 expression in PDX established from triple-negative breast cancers. Clin Cancer Res. 2018;24(11):2605–2615. doi:10.1158/1078-0432.CCR-17-349029463559
   PubMed Web of Science ®Google Scholar
• Arango NP, Yuca E, Zhao M, et al. Selinexor (KPT-330) demonstrates anti-tumor efficacy in preclinical models of triple-negative breast cancer. Breast Cancer Res. 2017;19(1):93. doi:10.1186/s13058-017-0878-628810913
   PubMed Web of Science ®Google Scholar